Can AI write prescriptions? A case from Utah 2026

In the state of Utah, the company Doctronic in January 2026 launched a service that allowed patients to get prescription refills through an AI chatbot without visiting a doctor, but after several months the state medical board required the program to stop.

How does Doctronic's service work

The principle of operation is straightforward: a patient opens the platform, answers questions from an AI chatbot, and gets a prescription refill online—without scheduling an appointment with a doctor, without visiting a clinic, without a physical examination. According to the developers, this solves a real problem in American medicine: lack of time for doctors and access barriers to specialists in small towns and rural areas.

Key facts about the program:

• Launch — January 2026, state of Utah
• Operator — Doctronic company
• Utah — first US state de facto allowing AI prescription issuance without a doctor
• Entire process conducted online via chatbot

According to Associated Press, the service launched without major announcements and operated for several months before attracting regulators' attention. This quiet launch exposes the core issue: Utah's legislation simply contained no direct prohibition on such a scheme.

Why is the medical board against it?

Utah's medical board took a hard position: the program violates standards of medical care and creates real risks to patient safety. The main argument is that an AI chatbot is fundamentally incapable of conducting a full medical examination.

Prescription refills without physical contact with a doctor means the system will miss patient condition deterioration, appearance of new symptoms, or potentially dangerous drug interactions. This is precisely why American medicine has requirements for regular visits to a doctor—even for stable chronic diseases.

Medical opinion in the US is divided. Some specialists believe that for routine refills of long-prescribed medications, a doctor visit is an excessive barrier, especially for patients in remote areas with limited access to healthcare. Others insist: any medical decision requires professional clinical evaluation, which an algorithm cannot replace.

A precedent for the entire country

The Doctronic story exposes a systemic problem: American medical regulation is falling behind the pace of AI services appearing. The company was able to launch the program precisely because state legislation lacked a direct prohibition. The medical board is forced to act retroactively—trying to stop an already-operating service with a real user base.

The outcome of this confrontation matters for the entire country. If Utah succeeds in shutting down Doctronic, it will create a legal precedent and signal other states—to introduce restrictions preemptively, before similar platforms appear. If the program continues operating, similar platforms will inevitably appear nationwide, and the question of safety standards will be raised at the federal level.

What does this mean

Utah unintentionally became the first testing ground for one of the key questions in applying AI to medicine: where is the boundary between useful automation of routine processes and inadmissible replacement of a doctor? The outcome of the confrontation between Doctronic and the medical board will largely determine how quickly AI services can enter American primary care—and on what terms.

Is it legal for neural networks to issue prescriptions?

The state of Utah allowed Doctronic company's program in January 2026, but after several months the state medical board required it to stop due to concerns about patient safety.

How does AI for prescription issuance work?

A patient opens the platform, answers questions from an AI chatbot, and gets a prescription refill online without scheduling an appointment with a doctor, traveling to a clinic, or having a physical examination.

How did Doctronic's AI service issue prescriptions?

A patient opened the platform, answered chatbot questions, and received a prescription refill online without scheduling with a doctor, physical examination, and clinic visit.